Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].
作者信息
Li Weihao, Huang Kai, Wen Fengbiao, Cui Guanghui, Guo Haizhou, He Zhanfeng, Zhao Song
机构信息
Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, PR China.
Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, PR China.
出版信息
EBioMedicine. 2024 Jun;104:105192. doi: 10.1016/j.ebiom.2024.105192. Epub 2024 Jun 3.
Abstract
摘要
相似文献
1
Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].撤回通知：“LINC00184沉默通过PTEN去甲基化抑制食管癌糖酵解并恢复线粒体氧化磷酸化”[《电子生物医学》44卷（2019年）第298 - 310页]
EBioMedicine. 2024 Jun;104:105192. doi: 10.1016/j.ebiom.2024.105192. Epub 2024 Jun 3.
2
LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN.LINC00184 沉默通过去甲基化 PTEN 抑制食管癌中的糖酵解并恢复线粒体氧化磷酸化。
EBioMedicine. 2019 Jun;44:298-310. doi: 10.1016/j.ebiom.2019.05.055. Epub 2019 Jun 11.
3
Serine 727 phosphorylation is necessary to induce the STAT3-mediated transcription of LINC00184 in oesophageal squamous cell carcinoma.丝氨酸 727 磷酸化是诱导食管鳞状细胞癌中 STAT3 介导的 LINC00184 转录所必需的。
Mol Cell Biochem. 2022 Jun;477(6):1775-1787. doi: 10.1007/s11010-022-04405-4. Epub 2022 Mar 21.
4
Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].撤回声明：“《对〈MicroRNA-134通过PLXNA1介导的MAPK信号通路预防食管鳞状细胞癌进展〉的勘误》[《E生物医学》46 (2019) 66 - 78]”[《E生物医学》55 (2020) 102772]
EBioMedicine. 2024 May;103:105106. doi: 10.1016/j.ebiom.2024.105106. Epub 2024 Apr 4.
5
Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].《关于“MicroRNA-134通过PLXNA1介导的MAPK信号通路抑制食管鳞状细胞癌进展”的撤稿声明》[《电子生物医学》46 (2019) 66 - 78]
EBioMedicine. 2024 May;103:105105. doi: 10.1016/j.ebiom.2024.105105. Epub 2024 Apr 4.
6
LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305.LINC00184通过海绵化miR-1305提高CNTN1表达促进卵巢癌细胞增殖和顺铂耐药。
Onco Targets Ther. 2021 Apr 19;14:2711-2726. doi: 10.2147/OTT.S280490. eCollection 2021.
7
Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.围海嘧啶靶向食管鳞癌细胞的糖酵解和线粒体氧化磷酸化：在抗癌治疗中的意义。
Phytomedicine. 2024 Jun;128:155539. doi: 10.1016/j.phymed.2024.155539. Epub 2024 Mar 15.
8
Long noncoding RNA LINC00184 facilitates the proliferation, metastasis, and adenine metabolism of cholangiocarcinoma via modulating hsa-miR-23b-3p/ANXA2 axis.长链非编码 RNA LINC00184 通过调节 hsa-miR-23b-3p/ANXA2 轴促进胆管癌的增殖、转移和腺嘌呤代谢。
Environ Toxicol. 2021 Aug;36(8):1576-1590. doi: 10.1002/tox.23154. Epub 2021 Apr 29.
9
Retraction notice to "The long noncoding RNA CASC2 inhibits tumorigenesis through modulating the expression of PTEN by targeting miR-18a-5p in esophageal carcinoma" [Experimental Cell Research 361 (2017) 30-38].撤回声明：“长链非编码RNA CASC2通过靶向miR-18a-5p调控PTEN表达抑制食管癌肿瘤发生”[《实验细胞研究》361(2017)30-38]
Exp Cell Res. 2018 Aug 1;369(1):176. doi: 10.1016/j.yexcr.2018.05.034.
10
Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].撤回声明：“HBV编码的miR-2通过下调TRIM35但上调RAN在肝癌细胞中发挥癌基因作用”[《电子生物医学》48卷（2019年）第117 - 129页]
EBioMedicine. 2021 Oct;72:103667. doi: 10.1016/j.ebiom.2021.103667.
Zotero 插件